13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001696778
Total reported value
$44.3M
$44.3M
62 檔
11.4%
At the close of Q1 2024, Worth Venture Partners, LLC disclosed equity holdings valued at approximately $44.3M, spread across 62 reported holdings.
During Q1 2024, Worth Venture Partners, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | Stock-Healthcare | 9.57% | — | — | |
| 2 | AIP | Arteris Inc | Stock-Other | 6.75% | — | +26.08% | |
| 3 | IHI | Ishares U.s. Medical Devices | ETF-Other | 6.04% | — | — | |
| 4 | ITIEUR | Iteris Inc | Stock-Other | 5.78% | — | -36.86% | |
| 5 | WEAV | Weave Communications Inc | Stock-Other | 5.36% | — | -25.97% | |
| 6 | SSTI | Soundthinking Inc | Stock-Other | 4.96% | — | +13.98% | |
| 7 | ✓ | Radcom LTD New | Stock-Other | 4.39% | — | — | |
| 8 | CTO | Cto Realty Growth Inc | Stock-Other | 3.19% | -0.77% | — | |
| 9 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 3.01% | — | — | |
| 10 | INSM | Insmed Inc | Stock-Healthcare | 2.78% | — | — | |
| 11 | SRPT | Sarepta Therapeutics, Inc. | Stock-Healthcare | 2.77% | — | +7.95% | |
| 12 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 2.56% | — | — | |
| 13 | EGAN | Egain CORP | Stock-Other | 2.46% | — | +67.18% | |
| 14 | WSR | Whitestone Reit | Stock-Other | 2.28% | -1.14% | EXIT | |
| 15 | HP5A | Equity Commonwealth | Stock-Other | 2.27% | — | — | |
| 16 | PLYM | Plymouth Industrial Reit Inc | Stock-Other | 2.18% | — | +17.74% | |
| 17 | EPR | Epr Properties | Stock-Real Estate | 2.08% | — | +34.86% | |
| 18 | AIOT | Powerfleet Inc | Stock-Other | 2.00% | +0.16% | NEW | |
| 19 | NSA | National Storage Affiliates | Stock-Real Estate | 1.80% | — | -12.66% | |
| 20 | SPG | Simon Property Group Inc | Stock-Real Estate | 1.72% | — | — | |
| 21 | KRG | Kite Realty Group Trust | Stock-Real Estate | 1.66% | — | +21.05% | |
| 22 | ALCO | Alico Inc | Stock-Other | 1.62% | -0.83% | EXIT | |
| 23 | BDN | Brandywine Realty Trust | Stock-Other | 1.60% | — | +5.26% | |
| 24 | ADC | Agree Realty CORP | Stock-Real Estate | 1.54% | — | +14.08% | |
| 25 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 1.52% | — | — | |
| 26 | ✓ | Playa Hotels & Resorts NV | Stock-Other | 1.49% | — | — | |
| 27 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | 1.32% | — | — | |
| 28 | QURE | uniQure N.V. | Stock-Other | 1.19% | — | — | |
| 29 | OPRA | Opera Ltd-adr | Stock-Other | 1.09% | +0.45% | -19.92% | |
| 30 | GEO | Geo Group Inc/the | Stock-Other | 0.99% | — | -0.56% | |
| 31 | CRNT | Ceragon Networks Ltd. | Stock-Other | 0.99% | — | -46.61% | |
| 32 | NOTVQ | Inotiv Inc | Stock-Other | 0.99% | — | — | |
| 33 | ✓ | Insmed Inc | Stock-Other | 0.85% | — | — | |
| 34 | ✓ | Pagaya Technologies LTD Cl | Stock-Other | 0.80% | — | — | |
| 35 | FENC | Fennec Pharmaceuticals Inc | Stock-Other | 0.76% | — | -92.70% | |
| 36 | ✓ | Innovid CORP | Stock-Other | 0.74% | — | — | |
| 37 | INFNEUR | Infinera CORP | Stock-Other | 0.71% | — | +57.85% | |
| 38 | RBBN | Ribbon Communications Inc | Stock-Other | 0.63% | +0.18% | NEW | |
| 39 | MQ | Marqeta Inc-a | Stock-Other | 0.61% | — | — | |
| 40 | STIM | Neuronetics Inc | Stock-Other | 0.53% | — | +62.21% | |
| 41 | MAMA | Mama's Creations Inc | Stock-Other | 0.52% | — | +23.52% | |
| 42 | LTRX | Lantronix Inc | Stock-Other | 0.48% | +0.23% | NEW | |
| 43 | WULF | Terawulf Inc | Stock-Financials | 0.42% | -0.72% | EXIT | |
| 44 | ✓ | Bit Digital Inc | Stock-Other | 0.37% | — | — | |
| 45 | AUGX | Augmedix Inc | Stock-Other | 0.37% | — | +0.09% | |
| 46 | TLS | Telos Corporation | Stock-Other | 0.35% | +0.29% | NEW | |
| 47 | ✓ | Akebia Therapeutics Inc | Stock-Other | 0.33% | — | — | |
| 48 | DNN | Denison Mines CORP | Stock-Other | 0.32% | — | — | |
| 49 | KORE | KORE Group Holdings, Inc. | Stock-Other | 0.25% | — | +27.17% | |
| 50 | ✓ | Iovance Biotherapeutics Inc | Stock-Other | 0.17% | — | — |
According to official SEC Form 13F filings, Worth Venture Partners, LLC reported a total U.S. public equity portfolio value of $44.3M across 62 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including JNJ, AIP, IHI) accounted for 11.4% of total reported equity market value during Q1 2024.
During Q1 2024, Worth Venture Partners, LLC's top holdings by market value included JNJ (9.6%)、AIP (6.8%)、IHI (6.0%). The largest single position, JNJ, represented 9.6% of total portfolio value.
In Q1 2024, Worth Venture Partners, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.